Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.
Guide · Evidence check
Sleep Peptides: What the Evidence Actually Shows
"Sleep peptides" is one of the fastest-growing corners of the peptide conversation — and one of the least honest. This guide walks through the compounds most often sold under that label, what the research really shows for each, and the uncomfortable headline: no peptide is an approved sleep treatment anywhere PCF's readers live. If your sleep is genuinely poor, there are better-evidenced places to start.
The short answer
No peptide holds a licence as a sleep or insomnia treatment from the MHRA or the FDA. The compounds marketed for sleep rest on evidence that is old, small, preclinical, or anecdotal — and most are sold as unlicensed "research chemicals".
For chronic insomnia, the first-line, best-evidenced treatment is CBT-I — not a compound at all. A credible clinic will tell you that before it sells you anything.
DSIP — the original "sleep peptide"
Delta sleep-inducing peptide earned its name from 1970s animal research associating it with deep slow-wave sleep. Half a century later, that name is still doing most of the work: human trials are few, small, and dated, and even the early studies were inconsistent. There is no robust modern clinical evidence that DSIP treats insomnia or improves sleep quality, and it is not an approved medicine in the UK or US. Read the full DSIP evidence page.
Epitalon — longevity claims, sleep framing
Epitalon is a synthetic pineal-gland-derived peptide most often marketed for longevity, with sleep benefits claimed via its supposed effect on melatonin regulation. The evidence base is largely preclinical plus older human studies from a single Russian research group — no robust completed human trials support either the longevity or the sleep claims. It is unapproved in the UK and US and sold as a research chemical. Read the full Epitalon evidence page.
Selank — calm, not sleep
Selank is a registered prescription medicine in Russia for generalised anxiety, usually as a nasal spray, and appears in sleep discussions because calmer people sleep better. That indirect logic is the whole story: it is not approved anywhere for sleep, is unapproved for anything in the UK and US, and its anxiety evidence has limited independent replication outside Russia. If anxiety is disrupting your sleep, that is a treatable condition deserving proper care. Read the full Selank evidence page.
Growth-hormone secretagogues — the indirect route
CJC-1295, ipamorelin, and MK-677 appear in sleep conversations because growth hormone is naturally released during deep sleep, and some users report sleeping more deeply. The connection is mechanistic and anecdotal — no sleep-outcome trials support prescribing them for sleep, all are unapproved medicines in the UK and US, and all are prohibited in tested sport. MK-677 also raises appetite and blood sugar, which is a poor trade for an unproven sleep benefit. See the MK-677 evidence page and ipamorelin.
What to do instead — and what to ask
Persistent poor sleep is a medical symptom with real, diagnosable causes — insomnia disorder, sleep apnoea, circadian disruption — and well-evidenced treatments, starting with CBT-I. Before spending anything on an unlicensed vial, speak to a doctor. If you do consult a clinic that discusses peptides in a sleep context, ask three questions: what evidence supports this for sleep specifically, what approved options should I try first, and how will we measure whether it is working?
Frequently asked questions
What are 'sleep peptides'?
It's a marketing category, not a medical one. The peptides most often sold under the label are DSIP (delta sleep-inducing peptide), epitalon, and selank, sometimes alongside growth-hormone secretagogues like CJC-1295 and ipamorelin whose users report sleep changes. None of them is an approved sleep treatment in the UK or US.
Does DSIP actually work for sleep?
The honest answer is that the evidence is limited and mixed. DSIP was named for its association with deep slow-wave sleep in 1970s animal research, but human trials are few, small, and dated, and even early studies were inconsistent. There is no robust modern clinical evidence that DSIP is an effective sleep treatment.
Is any peptide approved for insomnia?
No peptide is licensed as a sleep or insomnia treatment by the MHRA or the FDA. Approved insomnia care uses entirely different, well-studied options — and the first-line treatment for chronic insomnia is not a drug at all but CBT-I (cognitive behavioural therapy for insomnia).
Why do people say growth-hormone peptides improve sleep?
Growth hormone is released in pulses during deep sleep, so secretagogues like CJC-1295, ipamorelin, and MK-677 get discussed in sleep contexts, and some users report feeling they sleep more deeply. That connection is mechanistic and anecdotal rather than proven in sleep-outcome trials — and these compounds are prohibited in tested sport and unapproved as medicines in the UK and US.
What should I do if I have real sleep problems?
Persistent poor sleep deserves a proper assessment — insomnia, sleep apnoea, and circadian disorders are diagnosable, treatable conditions. Speak to a doctor before spending money on unlicensed products. If you still want to explore peptide-adjacent care, do it through a clinic that will assess you honestly rather than sell you a vial.
A note on this guide
Peptide Clinic Finder is an informational directory. This guide is general information to help you research options before speaking to a clinician; it is not medical advice, and it does not diagnose, prescribe, or recommend treatment. If sleep problems are affecting your life, please speak to a qualified clinician — effective, evidence-based help exists.